Description
Title: Falcigo Plus – Antimalarial Treatment for Malaria
Description:
Falcigo Plus is an antimalarial medication manufactured by Zydus Cadila. It combines Artesunate and Mefloquine, making it effective in treating chloroquine-resistant malaria, including cerebral malaria caused by Plasmodium falciparum.
Contents:
Artesunate 100 mg
Mefloquine 200 mg
Uses:
Falcigo Plus is indicated for:
Treatment of chloroquine-resistant malaria.
Management of cerebral malaria.
Treatment of uncomplicated malaria caused by Plasmodium species.
Side Effects:
Common Side Effects:
Nausea and Vomiting
Abdominal pain
Headache
Dizziness
Abnormal dreams
Serious Side Effects:
Abnormal liver function tests
Abnormal blood counts
Allergic reactions
Precautions:
Not suitable for individuals with known hypersensitivity to Artesunate or Mefloquine.
Consult a doctor if pregnant, planning a pregnancy, or breastfeeding.
Use with caution in patients with pre-existing liver or kidney conditions.
Directions for Use:
Take Falcigo Plus as prescribed by your healthcare provider.
It is recommended to take the tablet with food to enhance absorption and minimize gastrointestinal discomfort.
HSN Code:
3004, categorizing it under antimalarial pharmaceuticals.
There are no reviews yet.